Top News: Karyopharm Therapeutics (NASDAQ:KPTI), Companhia Siderurgica Nacional (NYSE:SID), NCI Building Systems Inc. (NYSE:NCS), Auxilium Pharmaceuticals (NASDAQ:AUXL), Westbury Bancorp (NASDAQ:WBB)

Karyopharm Therapeutics (NASDAQ:KPTI) major shareholder Marcin Czernik sold 12,795 shares of the company’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $38.07, for a total value of $487,105.65. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC. Karyopharm Therapeutics, Inc. (NASDAQ:KPTI) belongs to Healthcare sector. and weekly performance is 12.11%. On last trading day company shares ended up $40.36. Karyopharm Therapeutics, Inc. (NASDAQ:KPTI) distance from 50-day simple moving average (SMA50) is 7.64%.

Companhia Siderurgica Nacional (NYSE:SID) has received a “BB” credit rating from analysts at Morningstar. The firm’s “BB” rating indicates that the company is an above-average default risk. They also issued a neutral credit outlook for the company and gave their stock a three star rating. Companhia Siderurgica Nacional (NYSE:SID) shares fell -3.68% in last trading session and ended the day at $4.19. Companhia Siderurgica Nacional (NYSE:SID) quarterly performance is -1.41%.

NCI Building Systems (NYSE:NCS) released its earnings data on Monday. The company reported $0.10 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.09 by $0.01, Stock Ratings News reports. The company had revenue of $361.63 million for the quarter, compared to the consensus estimate of $352.68 million. During the same quarter last year, the company posted $0.02 earnings per share. NCI Building Systems’s revenue was up 14.0% compared to the same quarter last year. On 08 September, NCI Building Systems Inc. (NYSE:NCS) shares fell -0.54% and was closed at $20.09. NCS EPS growth in last 5 year was -15.00%. NCI Building Systems Inc. (NYSE:NCS) year to date (YTD) performance is 14.54%.

On 28 Aug 2014 Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL), a specialty biopharmaceutical company, today announced that data from trials evaluating the use of collagenase clostridium histolyticum (CCH) for treating two Dupuytren’s contracture (DC) cords concurrently in adult patients with a palpable cord will be presented at the upcoming 69th Annual Meeting of the American Society for Surgery of the Hand (ASSH) being held in Boston on September 18-20, 2014. XIAFLEX® (CCH) is a biologic approved in the U.S., EU, Canada and Australia for the treatment of adult DC patients with a palpable cord. Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL) ended the last trading day at $20.46. Company weekly volatility is calculated as 4.34%and price to cash ratio as 22.99. Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL) showed a weekly performance of 10.00%.

On 5 Aug 2014 Westbury Bancorp, Inc. (NASDAQ:WBB), the holding company (the “Company”) for Westbury Bank (the “Bank”), today announced net income of $69,000 for the third quarter ended June 30, 2014, compared to a net loss of $1.8 million for the quarter ended March 31, 2014, and a net loss of $446,000 for the third quarter ended June 30, 2013.  Net loss for the nine months ended June 30, 2014 was $1.7 million compared to net income of $721,000 for the nine months ended June 30, 2013.Westbury Bancorp, Inc. (NASDAQ:WBB) shares fell -0.99% in last trading session and ended the day on $15.04. its return on assets is -0.30%. Westbury Bancorp, Inc. (NASDAQ:WBB) quarterly performance is 3.51%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone